PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ROYAL BANK OF CANADA | 5,258 | $30,000 | 0.00% |
D. E. Shaw & Co., Inc. | 47,249 | $269,319 | 0.00% |
VANGUARD GROUP INC | 916,014 | $5,221,280 | 0.00% |
BESSEMER GROUP INC | 89 | $1 | 0.00% |
TD ASSET MANAGEMENT INC | 28,440 | $162,108 | 0.00% |
JANE STREET GROUP, LLC | 64,470 | $367,479 | 0.00% |
Cubist Systematic Strategies, LLC | 8,778 | $50,035 | 0.00% |
Point72 Asset Management, L.P. | 1,222 | $6,965 | 0.00% |
UBS Group AG | 980 | $5,586 | 0.00% |
Man Group plc | 22,663 | $129,179 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 22,455 | $127,994 | 0.00% |
OSAIC HOLDINGS, INC. | 500 | $2,850 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 12,759 | $72,726 | 0.00% |
BANK OF AMERICA CORP /DE/ | 28,186 | $160,660 | 0.00% |
WELLS FARGO & COMPANY/MN | 178 | $1,015 | 0.00% |
NORTHERN TRUST CORP | 21,167 | $120,652 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q1 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.